These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31096515)

  • 21. Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection.
    Niimi K; Fujishiro M; Goto O; Kodashima S; Minatsuki C; Hirayama I; Mochizuki S; Ono S; Yamamichi N; Kakushima N; Ichinose M; Koike K
    Dig Endosc; 2012 Mar; 24(2):110-6. PubMed ID: 22348835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vonoprazan vs proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: A meta-analysis of randomized controlled trials and observational studies.
    Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
    Medicine (Baltimore); 2020 Feb; 99(9):e19357. PubMed ID: 32118778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide.
    Kobayashi M; Takeuchi M; Hashimoto S; Mizuno K; Sato Y; Narisawa R; Aoyagi Y
    Dig Dis Sci; 2012 Jan; 57(1):119-26. PubMed ID: 21842241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
    Shin WG; Kim SJ; Choi MH; Kim KO; Jang HJ; Park CH; Baek IH; Kim KH; Baik GH; Kae SH; Kim JH; Kim HY
    Gastrointest Endosc; 2012 Apr; 75(4):739-47. PubMed ID: 22281110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study.
    Hamada K; Uedo N; Tonai Y; Arao M; Suzuki S; Iwatsubo T; Kato M; Shichijo S; Yamasaki Y; Matsuura N; Nakahira H; Kanesaka T; Yamamoto S; Akasaka T; Hanaoka N; Takeuchi Y; Higashino K; Ishihara R; Okada H; Iishi H; Fukui K; Shimokawa T
    J Gastroenterol; 2019 Feb; 54(2):122-130. PubMed ID: 29943163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
    Tomita T; Kim Y; Yamasaki T; Okugawa T; Kondo T; Toyoshima F; Sakurai J; Tanaka J; Morita T; Oshima T; Fukui H; Hori K; Watari J; Matsumoto T; Miwa H
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1441-6. PubMed ID: 22497427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for 4 weeks.
    Oh TH; Jung HY; Choi KD; Lee GH; Song HJ; Choi KS; Chung JW; Byeon JS; Myung SJ; Yang SK; Kim JH
    Dig Dis Sci; 2009 Jul; 54(7):1494-9. PubMed ID: 19005762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of administration of a proton pump inhibitor before endoscopic submucosal dissection for differentiated early gastric cancer with ulcer.
    Myung YS; Hong SJ; Han JP; Park KW; Ko BM; Lee MS
    Gastric Cancer; 2017 Jan; 20(1):200-206. PubMed ID: 26661593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study.
    Lee SH; Lee CK; Chung IK; Shim YS; Lee TH; Lee SH; Kim HS; Park SH; Kim SJ
    Dig Dis Sci; 2012 Feb; 57(2):429-34. PubMed ID: 22001942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of mucoprotective agents in endoscopic submucosal dissection-derived ulcers: A systematic review.
    Pittayanon R; Martel M; Barkun A
    J Gastroenterol Hepatol; 2018 Dec; 33(12):1948-1955. PubMed ID: 29870582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial.
    Kawai D; Takenaka R; Ishiguro M; Okanoue S; Gotoda T; Kono Y; Takemoto K; Tsugeno H; Fujiki S
    BMC Gastroenterol; 2021 May; 21(1):236. PubMed ID: 34022796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers.
    Jung DH; Park JC; Lee YC; Lee SK; Shin SK; Chung H; Park JJ; Kim JH; Youn YH; Park H
    J Clin Gastroenterol; 2021 Mar; 55(3):233-238. PubMed ID: 32341237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy.
    Nakamura K; Ihara E; Akiho H; Akahoshi K; Harada N; Ochiai T; Nakamura N; Ogino H; Iwasa T; Aso A; Iboshi Y; Takayanagi R
    Gut Liver; 2016 Nov; 10(6):917-924. PubMed ID: 27282261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of PPIs Alone, PPIs plus cytoprotective agent, and H2RA plus cytoprotective agent on ulcer healing after endoscopic submucosal dissection: A prospective randomized controlled trial.
    Lee JY; Jang JS
    Arab J Gastroenterol; 2021 Jun; 22(2):115-120. PubMed ID: 33551349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of short-term proton pump inhibitor plus anti-ulcer drug on the healing of endoscopic submucosal dissection-derived artificial ulcer: a randomized controlled trial.
    Nakamura M; Tahara T; Shiroeda H; Matsunaga K; Otsuka T; Yonemura J; Shibata T; Arisawa T
    Hepatogastroenterology; 2015; 62(137):219-24. PubMed ID: 25911899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose PPI to prevent bleeding after ESD: A multicenter randomized controlled study.
    Yang L; Qi J; Chen W; Guo Q; Xie R; Zhao Z; Qin S; Liu A; Den M; Fan C; Bai J; Lin H; Guo H; Yang S
    Biomed Pharmacother; 2021 Apr; 136():111251. PubMed ID: 33450486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of early Helicobacter pylori eradication on the healing of ESD-induced artificial ulcers: A retrospective study.
    Song WC; Wang XF; Lv WW; Xu XY; Tian M
    Medicine (Baltimore); 2019 May; 98(22):e15807. PubMed ID: 31145312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is proton-pump inhibitor effective in preventing postoperative bleeding after esophageal endoscopic submucosal dissection?
    Tanaka I; Tarasawa K; Saito H; Hirasawa D; Fujimori K; Fushimi K; Matsuda T
    Dis Esophagus; 2024 Jan; 37(2):. PubMed ID: 37815127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: prospective randomized study.
    Asakuma Y; Kudo M; Matsui S; Okada M; Kawasaki M; Umehara Y; Ichikawa T; Kitai S
    Hepatogastroenterology; 2009; 56(94-95):1270-3. PubMed ID: 19950775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vonoprazan versus proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: Protocol for meta-analysis of randomized controlled trials and observational studies.
    Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
    Medicine (Baltimore); 2019 Feb; 98(8):e14381. PubMed ID: 30813139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.